1. Home
  2. CENT vs GPCR Comparison

CENT vs GPCR Comparison

Compare CENT & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Garden & Pet Company

CENT

Central Garden & Pet Company

HOLD

Current Price

$39.01

Market Cap

2.4B

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$39.33

Market Cap

2.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENT
GPCR
Founded
1955
2016
Country
United States
United States
Employees
6000
N/A
Industry
Consumer Specialties
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.8B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
CENT
GPCR
Price
$39.01
$39.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
12
Target Price
$50.00
$103.17
AVG Volume (30 Days)
41.9K
761.8K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.60
N/A
Revenue Next Year
$2.04
N/A
P/E Ratio
$15.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.77
$15.80
52 Week High
$41.53
$94.90

Technical Indicators

Market Signals
Indicator
CENT
GPCR
Relative Strength Index (RSI) 55.48 41.94
Support Level $35.18 $30.82
Resistance Level $39.85 $40.29
Average True Range (ATR) 1.04 2.11
MACD 0.08 0.42
Stochastic Oscillator 49.16 41.33

Price Performance

Historical Comparison
CENT
GPCR

About CENT Central Garden & Pet Company

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: